Clinical trial LOXO-PIK-21001
A study of LOXO-783 Administered as Monotherapy and in Combination with Anticancer Therapies for Patients with Advanced Breast Cancer and Other Solid Tumors with a PIK3CA H1047R Mutation.
| Organ | Multiple |
|---|---|
| Trial status | Trial closed for recruitment |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 1/1b |
| Academic trial | Non |
| Sponsor | Loxo Oncology |
| EudraCT Identifier | 2022-000175-40A |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT05307705 |
| Last update |